Primary Site >> Liver Cancer

Gene >> DIAPH3

Journal: EMBO Mol Med. 2012 Aug;4(8):743-60.
Title: DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.
Author: Hager, Martin H|Morley, Samantha|Bielenberg, Diane R|Gao, Sizhen|Morello, Matteo|Holcomb, Ilona N|Liu, Wennuan|Mouneimne, Ghassan|Demichelis, Francesca|Kim, Jayoung|Solomon, Keith R|Adam, Rosalyn M|Isaacs, William B|Higgs, Henry N|Vessella, Robert L|Di Vi
PMID: 22593025
Journal: Toxicology. 2016 Mar 28;350-352:31-9.
Title: Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma.
Author: Rieswijk, Linda|Claessen, Sandra M H|Bekers, Otto|van Herwijnen, Marcel|Theunissen, Daniel H J|Jennen, Danyel G J|de Kok, Theo M C M|Kleinjans, Jos C S|van Breda, Simone G J
PMID: 27153756
Journal: Mol Cell Biochem. 2018 Jan;438(1-2):183-190.
Title: DIAPH3 promoted the growth, migration and metastasis of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
Author: Dong, Li|Li, Zhijun|Xue, Liying|Li, Gang|Zhang, Cuiying|Cai, Zhihui|Li, Hui|Guo, Ruifang
PMID: 28795316